According to a new report by Expert Market Research, the Vietnam Vaccine Market is witnessing robust expansion, valued at USD 3.93 USD Billion in 2025 and projected to grow at a CAGR of 9.6% during 2026–2035, ultimately reaching USD 9.83 Billion by 2035. The Vietnam Vaccine Market is being shaped by rising immunization awareness, expanding healthcare infrastructure, and continuous advancements in vaccine development technologies. Increasing focus on preventive healthcare and government-led vaccination programs is further accelerating market adoption across both urban and rural regions. Expert Market Research highlights that evolving disease patterns and strong public-private partnerships are also contributing significantly to sustained market growth across the forecast period.

The Vietnam Vaccine Market is experiencing notable transformation due to the integration of modern biotechnology platforms and enhanced cold-chain logistics. Increasing collaboration between global pharmaceutical companies and domestic healthcare providers is improving accessibility and distribution efficiency. Rising prevalence of infectious diseases and growing pediatric vaccination programs are further boosting demand across multiple vaccine categories. Expert Market Research also notes that digital health tracking systems and government immunization campaigns are improving vaccine coverage rates nationwide, supporting long-term market stability and growth potential.

Claim Your Free Sample Report with Comprehensive TOC

Overall, the Vietnam Vaccine Market outlook remains highly positive, supported by rising healthcare investments and increased awareness of preventive medicine. With continuous innovation and policy support, the market is expected to expand steadily over the forecast period, driven by both public and private sector contributions.

Market Overview by Expert Market Research

The Vietnam Vaccine Market is evolving rapidly as healthcare systems strengthen immunization frameworks and expand vaccine accessibility. Increasing demand for advanced vaccines, including combination and recombinant formulations, is reshaping product development strategies. Expert Market Research emphasizes that Vietnam’s healthcare modernization initiatives and rising disease prevention awareness are key drivers of sustained vaccine adoption across all age groups. The market is also benefiting from improved regulatory frameworks that support faster vaccine approvals and wider distribution networks.

Market Size & Forecast: Expert Market Research Projections

The Vietnam Vaccine Market was valued at USD 3.93 USD Billion in 2025 and is projected to expand at a CAGR of 9.6% from 2026 to 2035, reaching USD 9.83 Billion by 2035. Expert Market Research indicates that this growth trajectory reflects strong immunization demand, increasing healthcare expenditure, and advancements in vaccine production technologies across the country.

Macroeconomic & Industry Linkage Analysis

Macroeconomic stability in Vietnam, combined with rising healthcare investments, is positively influencing vaccine market expansion. Government focus on universal immunization coverage and public health resilience is strengthening demand for both routine and emergency vaccines. Expert Market Research highlights that Vietnam’s integration into global pharmaceutical supply chains is improving access to advanced vaccine technologies and reducing dependency on limited domestic production capabilities.

Additionally, increased foreign direct investment in the healthcare sector is enabling infrastructure development, including cold-chain logistics and vaccine storage facilities. These improvements are critical for maintaining vaccine efficacy and ensuring timely distribution across remote and urban regions.

Key Growth Drivers

• Rising Infectious Disease Burden: Increasing prevalence of viral and bacterial infections is driving vaccine demand across all demographics.
• Government Immunization Programs: Strong public vaccination campaigns are expanding coverage nationwide.
• Technological Advancements: Innovations such as mRNA and recombinant vaccines are enhancing efficacy.
• Expanding Healthcare Infrastructure: Improved hospitals and cold-chain systems support wider vaccine distribution.
• Growing Public Awareness: Increased focus on preventive healthcare is boosting vaccine adoption.

Market Trends

One of the key trends in the Vietnam Vaccine Market is the growing adoption of advanced vaccine technologies such as mRNA and viral vector platforms. Expert Market Research notes that pharmaceutical companies are increasingly investing in research and development to introduce more effective and targeted vaccines for emerging diseases.

Another significant trend is the digitalization of immunization tracking systems, which is improving efficiency in vaccine distribution and monitoring. These advancements are enhancing transparency and enabling better healthcare planning across Vietnam.

Market Challenges & Risk Factors

Despite strong growth prospects, the Vietnam Vaccine Market faces challenges such as supply chain disruptions and cold-chain dependency. Maintaining temperature-sensitive vaccine integrity remains a critical operational challenge, particularly in remote regions with limited infrastructure.

Additionally, reliance on imported raw materials and vaccine components exposes the market to global supply chain fluctuations, which may impact availability and pricing stability.

Market Opportunities & White Space Areas

Emerging opportunities include local vaccine manufacturing expansion and increased investment in biotechnology research. Expert Market Research identifies significant white space in adult vaccination programs, which remain underdeveloped compared to pediatric immunization coverage.

There is also growing potential in preventive oncology vaccines and allergy-based immunization solutions, which are expected to gain traction over the forecast period.

Value Chain & Supply Chain Analysis

The vaccine value chain in Vietnam includes research and development, raw material procurement, manufacturing, cold-chain logistics, and distribution through hospitals and pharmacies. Efficient coordination across these stages is essential to maintain vaccine quality and ensure timely delivery. Expert Market Research highlights that improvements in logistics infrastructure are reducing wastage and enhancing supply chain resilience.

Market Segmentation Analysis

By Product Type

• Multivalent Vaccines
• Monovalent Vaccines

By Type

• Subunit Vaccines
• Inactivated Vaccines
• Live Attenuated Vaccines
• mRNA Vaccines
• Viral Vector Vaccines

By Route Of Administration

• Oral
• Parenteral
• Nasal

By Disease Indication

• Viral Diseases
• Bacterial Vaccines
• Cancer Vaccines
• Allergy Vaccines

By Age

• Pediatric
• Adult

By End User

• Hospital Pharmacies
• Retail Pharmacies
• Government Suppliers
• Others

Competitive Landscape

The Vietnam Vaccine Market is highly competitive, with leading global pharmaceutical companies actively participating in vaccine supply and development. Major players include GlaxoSmithKline plc, Merck & Co., Sanofi, Pfizer Inc., AstraZeneca plc, and Johnson & Johnson Services, Inc. Expert Market Research notes that these companies are focusing on strategic collaborations, research investments, and distribution partnerships to strengthen their market presence in Vietnam.

Frequently Asked Questions (FAQs)

1. What is the current size of the Vietnam Vaccine Market?
The Vietnam Vaccine Market was valued at USD 3.93 USD Billion in 2025.

2. What is the projected CAGR of the Vietnam Vaccine Market?
The market is expected to grow at a CAGR of 9.6% from 2026 to 2035.

3. Which region dominates the Vietnam Vaccine Market?
Urban regions of Vietnam currently dominate due to better healthcare infrastructure and higher vaccination awareness.

4. Who are the key players in the Vietnam Vaccine Market?
Key players include GlaxoSmithKline plc, Merck & Co., Sanofi, Pfizer Inc., AstraZeneca plc, and Johnson & Johnson Services, Inc.

5. What are the major growth drivers of the Vietnam Vaccine Market?
Key drivers include rising disease burden, government immunization programs, and technological advancements in vaccines.

6. What are the key segments of the Vietnam Vaccine Market?
The market is segmented by product type, vaccine type, administration route, disease indication, age group, and end users.

7. What challenges does the Vietnam Vaccine Market face?
Challenges include cold-chain logistics limitations and dependency on imported vaccine components.

8. What is the forecast value of the Vietnam Vaccine Market by 2035?
The Vietnam Vaccine Market is expected to reach USD 9.83 USD Billion by 2035.

"

About Us:

Expert Market Research is a global market intelligence and consulting platform by Claight delivering data-driven insights across commodities, chemicals, energy, and industrial markets. We design our research to support businesses, analysts, investors, and procurement teams in understanding price trends, supply-demand dynamics, competitive landscapes, gaining competitive intelligence, benchmarking best practices, and developing long-term market outlooks.

Our robust research methodologies, combined with validated primary and secondary data, ensure accuracy, consistency, and relevance. Our analysis is widely used not only for strategic planning, market-entry assessments, and sourcing decisions, but also for investment evaluation across international markets. Our strong emphasis on transparency, factual reporting, and regular data updates to reflect real-time market conditions always keeps you ahead of the curve.

Media Contact:

Company Name: Claight Corporation
Email: sales@expertmarketresearch.com
Toll Free Number: +1-415-325-5166 | +44-702-402-5790
Address: C-130 Sector 2 Noida, Uttar Pradesh 201301
Website: https://www.expertmarketresearch.com